Omnicell (OMCL)

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

Company profile

Ticker

OMCL

Exchange

NASDAQ

Website

www.omnicell.com

CEO

Randall Lipps

Incorporated

California

Location

California

Fiscal year end

Dec 31

Sector

Manufacturing > Electronic Computer Manufacturing

Industry (SIC)

Electronic Computers

Apple • Dell • Super Micro Computer • Fitbit • Zepp Health • One Stop Systems • Socket Mobile • First Capital International • Sector 5 • Helo ...

Former names

OMNICELL COM /CA/, OMNICELL INC /CA/

SEC CIK

0000926326

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Omnicell Pty Ltd • Omnicell (Beijing) Technology Co. Ltd • Omnicell GmbH • Omnicell SAS • Omnicell S.r.l. • Omnicell India Private Limited • Omnicell B.V. • Omnicell Limited • ateb, Inc. • RxInnovation Inc. ...

IRS number

943166458

OMCL stock data

1M 1Y 5Y

News

From Benzinga Pro

Omnicell, Southwestern Energy, Ormat Technologies Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

28 Jun 22

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20220628-1453777/1453777_ehc4np6cdk4ccmp4cohr4.pdf PRESS RELEASE Omnicell, Southwestern Energy and Ormat Technologies Set to Join S&P

Wells Fargo Maintains Overweight on Omnicell, Lowers Price Target to $158

3 May 22

Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $188 to $158.

Piper Sandler Maintains Overweight on Omnicell, Lowers Price Target to $162

3 May 22

Piper Sandler analyst Sean Wieland maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $181 to $162.

Omnicell Q1 Adj. EPS $0.83 Beats $0.68 Estimate, Sales $318.83M Beat $314.36M Estimate

28 Apr 22

Stocks That Hit 52-Week Lows On Thursday

28 Apr 22

Press releases

From Benzinga Pro

Omnicell, Southwestern Energy and Ormat Technologies Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

28 Jun 22

NEW YORK, June 28, 2022 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices: S&P SmallCap 600 constituent

Omnicell Announces Financial Results for First Quarter 2022

28 Apr 22

GAAP and non-GAAP revenues of $319 million GAAP net income per diluted share of $0.17 Non-GAAP net income per diluted share of $0.83 Launched innovative IVX Station robotic compounding technology Omnicell, Inc.

Omnicell to Release First Quarter 2022 Financial Results on April 28, 2022

5 Apr 22

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2022, after market

Analyst ratings and price targets

Last 3 months

Average target

$160.00

Low target

$158.00

High target

$162.00

Calendar

9 May 22

2 Jul 22

31 Dec 22

Financial summary

Financial statements Chart OMCL financial data

Quarter (USD)	Mar 22	Dec 21	Sep 21	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	288.36M	288.36M	288.36M	288.36M	288.36M	288.36M
Cash burn (monthly)	22.42M	21.75M	(no burn)	(no burn)	5.33M	(no burn)
Cash used (since last report)	68.73M	66.69M	n/a	n/a	16.35M	n/a
Cash remaining	219.63M	221.67M	n/a	n/a	272.02M	n/a
Runway (months of cash)	9.8	10.2	n/a	n/a	51.0	n/a

Beta Read what these cash burn values mean

Financial data from Omnicell earnings reports.

Recent insider trades

OMCL insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
16 Jun 22	Scott Peter Seidelmann	Common Stock	Sell	Dispose S	No	Yes	111.0194	550	61.06K	40,789
16 Jun 22	Scott Peter Seidelmann	Common Stock	Sell	Dispose S	No	Yes	110.0099	3,208	352.91K	41,339
16 Jun 22	Scott Peter Seidelmann	Common Stock	Sell	Dispose S	No	Yes	108.56	7	759.92	44,547
15 Jun 22	Dan S Johnston	Common Stock	Payment of exercise	Dispose F	No	No	113.11	2,161	244.43K	32,730
15 Jun 22	Christine Marie Mellon	Common Stock	Payment of exercise	Dispose F	No	No	113.11	1,227	138.79K	23,883
15 Jun 22	Scott Peter Seidelmann	Common Stock	Payment of exercise	Dispose F	No	No	113.11	3,826	432.76K	44,554
15 Jun 22	Spears Joseph Brian	Common Stock	Payment of exercise	Dispose F	No	No	113.11	138	15.61K	12,239
15 Jun 22	Peter J. Kuipers	Common Stock	Payment of exercise	Dispose F	No	No	113.11	4,193	474.27K	61,326

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

OMCL institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	382	409	-6.6%
Opened positions	45	66	-31.8%
Closed positions	72	34	+111.8%
Increased positions	160	124	+29.0%
Reduced positions	130	167	-22.2%

13F shares	Current	Prev Q	Change
Total value	5.92B	8.23B	-28.0%
Total shares	45.73M	45.61M	+0.3%
Total puts	19.2K	51.1K	-62.4%
Total calls	35K	27.2K	+28.7%
Total put/call ratio	0.5	1.9	-70.8%

Largest owners	Shares	Value	Change
BLK Blackrock	7.42M	$960.38M	+6.2%
Vanguard	4.75M	$615.45M	+0.3%
Wellington Management	2.26M	$292.9M	-10.6%
Conestoga Capital Advisors	1.69M	$219.01M	+12.5%
IVZ Invesco	1.55M	$200.23M	+17.0%
STT State Street	1.44M	$186.84M	+3.6%
Clearbridge Advisors	1.14M	$147.19M	+8.9%
CS Credit Suisse	1.1M	$142.81M	+49.8%
MCQEF Macquarie	1.08M	$140.23M	-2.3%
American Century Companies	850.25K	$110.1M	+17.7%

Largest transactions	Shares	Bought/sold	Change
Victory Capital Management	49.01K	-473.03K	-90.6%
BLK Blackrock	7.42M	+433.17K	+6.2%
Jackson Square Partners	370.21K	-370.52K	-50.0%
CS Credit Suisse	1.1M	+366.84K	+49.8%
Norges Bank	0	-356.59K	EXIT
Wellington Management	2.26M	-269.58K	-10.6%
Thrivent Financial For Lutherans	269.85K	+234.09K	+654.6%
IVZ Invesco	1.55M	+224.79K	+17.0%
SG Americas Securities	27.45K	-223.45K	-89.1%
PFG Principal Financial Group Inc - Registered Shares	299.41K	-213.35K	-41.6%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Cardinal Health • CERNER • Mckesson • Grifols SA - ADR - Level III • Tabula Rasa HealthCare

Risks

Changes to the 340B Program could negatively impact our 340B Program-related services.

Management Discussion

Product revenues represented 71% of total revenues for both the three months ended March 31, 2022 and 2021. Product revenues increased by $47.8 million, due to increased customer demand, primarily within our automated dispensing systems business.
Services and other revenues represented 29% of total revenues for both the three months ended March 31, 2022 and 2021. Services and other revenues include revenues from technical services; SaaS, subscription software, and technology-enabled services; and other services. Services and other revenues increased by $19.2 million, primarily due to revenues from our recent acquisitions of FDS Amplicare, ReCept, and MarkeTouch Media.
Our international sales represented 10% and 11% of total revenues for the three months ended March 31, 2022 and 2021, respectively, and are expected to be affected by foreign currency exchange rate fluctuations. We are unable to predict the extent to which revenues in future periods will be impacted by changes in foreign currency exchange rates.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accelerated, accreditation, accrediting, Additionally, ambulatory, applied, apply, attack, attorney, attract, Australia, beneficial, breach, breakdown, bring, bringing, bundled, bundling, capable, catastrophic, ceiling, civil, clear, CMS, compel, complement, composed, concentration, conduct, corrective, Cosmetic, counsel, criminal, cybersecurity, damage, damaging, database, DEA, deficit, derecognized, detect, detecting, detection, device, disaster, disposable, disseminate, effectuating, encounter, engineering, enrolled, environmental, expend, expertise, force, forfeiture, found, foundation, frame, function, functionality, functioning, governmental, guide, halfway, handle, handling, HHS, HIPAA, host, Hub, Human, impose, imposed, imposing, inappropriate, incident, indemnification, indirectly, inflationary, influence, inherit, Inspector, intensive, intrusion, investigation, irrevocable, irrevocably, Justice, listing, log, longstanding, malware, mandatory, MarkeTouch, Media, mobile, narrowly, nascent, noteholder, notification, notified, offsite, older, open, outset, password, percentage, perioperative, pervasive, premarket, prescribing, prohibitive, proper, properly, PSU, qualified, ransomware, ReCept, recovery, redesign, Redfish, Reinvestment, rely, remedial, remediate, repair, reputation, respond, restore, restoring, retroactively, routine, RSA, RSU, safeguard, satisfactory, sensitive, shown, slight, Spoke, store, Storefront, streamline, streamlined, stringent, surveillance, tailored, tenure, Toucan, track, tracking, treatment, trial, UDI, unauthorized, unaware, unique, verify, vulnerable, written

Removed: amending, amortize, annually, answer, Apothecary, began, budget, BW, cancel, capitalized, capture, CareScheduler, clarifying, commercially, compete, confidence, contracted, decreased, depending, differentiated, disaggregation, disease, evaluate, evolve, exclusive, exit, exited, expenditure, experienced, expired, extended, extension, extinguishment, field, filled, globally, half, heightening, HSBC, identified, inability, increasingly, ineffective, infringing, install, intend, largely, Link, lost, misappropriating, Morgan, Nasdaq, negotiated, onset, outcome, outreach, performed, planned, play, power, predicted, prospective, Provision, PSGH, rapidly, reduced, refill, refinancing, remain, remained, remote, removing, response, returning, roadmap, Rule, scheduling, seller, significantly, Simplifying, site, split, strength, substantial, successfully, sustained, Synchronization, syndicate, testing, transform, treat, USA, vaccination, vaccine, violating, virtualization, vital, Weak, work

From filing 10-Q 2022 Q1

Financial reports

View all